Helius Medical Technologies, Inc.

HSM.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HSM.TO stands at 0. In comparison, VMD.TO has a market cap of 402.2M. Regarding current trading prices, HSM.TO is priced at CA$18.35, while VMD.TO trades at CA$10.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HSM.TO currently has a P/E ratio of -1.73, whereas VMD.TO's P/E ratio is 32.66. In terms of profitability, HSM.TO's ROE is -2.91%, compared to VMD.TO's ROE of +0.06%. Regarding short-term risk, HSM.TO is less volatile compared to VMD.TO. This indicates potentially lower risk in terms of short-term price fluctuations for HSM.TO.Check VMD.TO's competition here

HSM.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HSM.TO stands at 0. In comparison, PRN.TO has a market cap of 232.3M. Regarding current trading prices, HSM.TO is priced at CA$18.35, while PRN.TO trades at CA$7.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HSM.TO currently has a P/E ratio of -1.73, whereas PRN.TO's P/E ratio is -4.63. In terms of profitability, HSM.TO's ROE is -2.91%, compared to PRN.TO's ROE of -0.71%. Regarding short-term risk, HSM.TO is less volatile compared to PRN.TO. This indicates potentially lower risk in terms of short-term price fluctuations for HSM.TO.Check PRN.TO's competition here

HSM.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HSM.TO stands at 0. In comparison, TMD.TO has a market cap of 128.3M. Regarding current trading prices, HSM.TO is priced at CA$18.35, while TMD.TO trades at CA$1.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HSM.TO currently has a P/E ratio of -1.73, whereas TMD.TO's P/E ratio is -0.65. In terms of profitability, HSM.TO's ROE is -2.91%, compared to TMD.TO's ROE of -1.36%. Regarding short-term risk, HSM.TO is less volatile compared to TMD.TO. This indicates potentially lower risk in terms of short-term price fluctuations for HSM.TO.Check TMD.TO's competition here

HSM.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HSM.TO stands at 0. In comparison, QIPT.TO has a market cap of 127.7M. Regarding current trading prices, HSM.TO is priced at CA$18.35, while QIPT.TO trades at CA$3.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HSM.TO currently has a P/E ratio of -1.73, whereas QIPT.TO's P/E ratio is -10.89. In terms of profitability, HSM.TO's ROE is -2.91%, compared to QIPT.TO's ROE of -0.07%. Regarding short-term risk, HSM.TO is less volatile compared to QIPT.TO. This indicates potentially lower risk in terms of short-term price fluctuations for HSM.TO.Check QIPT.TO's competition here

HSM.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HSM.TO stands at 0. In comparison, NVCN.TO has a market cap of 110.8M. Regarding current trading prices, HSM.TO is priced at CA$18.35, while NVCN.TO trades at CA$40.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HSM.TO currently has a P/E ratio of -1.73, whereas NVCN.TO's P/E ratio is -1.96. In terms of profitability, HSM.TO's ROE is -2.91%, compared to NVCN.TO's ROE of -1.21%. Regarding short-term risk, HSM.TO is more volatile compared to NVCN.TO. This indicates potentially higher risk in terms of short-term price fluctuations for HSM.TO.Check NVCN.TO's competition here

HSM.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HSM.TO stands at 0. In comparison, BLO.CN has a market cap of 70.2M. Regarding current trading prices, HSM.TO is priced at CA$18.35, while BLO.CN trades at CA$0.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HSM.TO currently has a P/E ratio of -1.73, whereas BLO.CN's P/E ratio is -20.33. In terms of profitability, HSM.TO's ROE is -2.91%, compared to BLO.CN's ROE of -0.89%. Regarding short-term risk, HSM.TO is less volatile compared to BLO.CN. This indicates potentially lower risk in terms of short-term price fluctuations for HSM.TO.Check BLO.CN's competition here

HSM.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HSM.TO stands at 0. In comparison, ATE.TO has a market cap of 15.6M. Regarding current trading prices, HSM.TO is priced at CA$18.35, while ATE.TO trades at CA$0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HSM.TO currently has a P/E ratio of -1.73, whereas ATE.TO's P/E ratio is -0.84. In terms of profitability, HSM.TO's ROE is -2.91%, compared to ATE.TO's ROE of -0.40%. Regarding short-term risk, HSM.TO is less volatile compared to ATE.TO. This indicates potentially lower risk in terms of short-term price fluctuations for HSM.TO.Check ATE.TO's competition here

HSM.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HSM.TO stands at 0. In comparison, PMED.CN has a market cap of 4.8M. Regarding current trading prices, HSM.TO is priced at CA$18.35, while PMED.CN trades at CA$0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HSM.TO currently has a P/E ratio of -1.73, whereas PMED.CN's P/E ratio is -1.25. In terms of profitability, HSM.TO's ROE is -2.91%, compared to PMED.CN's ROE of +2.13%. Regarding short-term risk, HSM.TO is more volatile compared to PMED.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HSM.TO.Check PMED.CN's competition here

HSM.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HSM.TO stands at 0. In comparison, MYTC.CN has a market cap of 2.2M. Regarding current trading prices, HSM.TO is priced at CA$18.35, while MYTC.CN trades at CA$0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HSM.TO currently has a P/E ratio of -1.73, whereas MYTC.CN's P/E ratio is -1.60. In terms of profitability, HSM.TO's ROE is -2.91%, compared to MYTC.CN's ROE of +1.01%. Regarding short-term risk, HSM.TO is more volatile compared to MYTC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HSM.TO.Check MYTC.CN's competition here

HSM.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HSM.TO stands at 0. In comparison, ASTI.CN has a market cap of 414K. Regarding current trading prices, HSM.TO is priced at CA$18.35, while ASTI.CN trades at CA$0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HSM.TO currently has a P/E ratio of -1.73, whereas ASTI.CN's P/E ratio is -0.50. In terms of profitability, HSM.TO's ROE is -2.91%, compared to ASTI.CN's ROE of +0.18%. Regarding short-term risk, HSM.TO is more volatile compared to ASTI.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HSM.TO.Check ASTI.CN's competition here

HSM.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HSM.TO stands at 0. In comparison, IME.CN has a market cap of 162.5K. Regarding current trading prices, HSM.TO is priced at CA$18.35, while IME.CN trades at CA$0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HSM.TO currently has a P/E ratio of -1.73, whereas IME.CN's P/E ratio is -0.19. In terms of profitability, HSM.TO's ROE is -2.91%, compared to IME.CN's ROE of +0.20%. Regarding short-term risk, HSM.TO is more volatile compared to IME.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HSM.TO.Check IME.CN's competition here

HSM.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HSM.TO stands at 0. In comparison, AVBT.CN has a market cap of 123.7K. Regarding current trading prices, HSM.TO is priced at CA$18.35, while AVBT.CN trades at CA$0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HSM.TO currently has a P/E ratio of -1.73, whereas AVBT.CN's P/E ratio is -0.20. In terms of profitability, HSM.TO's ROE is -2.91%, compared to AVBT.CN's ROE of +4.09%. Regarding short-term risk, HSM.TO is more volatile compared to AVBT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HSM.TO.Check AVBT.CN's competition here